FDA clears Moderna’s first mRNA flu shot for adults 50 and older
What’s next: Moderna expects limited doses within weeks, while it must run another study to confirm benefit in adults 65 and older.
The Straits Times, PBS NewsHour +2
What’s next: Moderna expects limited doses within weeks, while it must run another study to confirm benefit in adults 65 and older.
What's next: The FDA is expected to decide by Aug. 5 on what could become the first mRNA-based seasonal flu vaccine.